FDA Inspection 564155 — Ascension Clinical Research Institute IRB
The FDA completed an inspection of Ascension Clinical Research Institute IRB on February 17, 2009 in Milwaukee, WI. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 17, 2009
- Fiscal Year
- 2009
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Milwaukee, WI (United States)
Additional Details
IRB